Literature DB >> 24426328

Hemoglobin e syndromes: emerging diagnostic challenge in north India.

Anjali Sharma1, Sadhna Marwah1, Gurdeep Buxi1, Rajbala Yadav1.   

Abstract

Hemoglobin E (HbE) is one of the world's most common and important mutations. HbE disorders may be found in heterozygous (AE), homozygous (EE) and compound heterozygous state. It is important to distinguish HbE disorders diagnostically because of marked differences in clinical course among different genotypes. To find out whether RBC indices as obtained from automated cell counter can provide a clue to the diagnosis of HbE disease. This study was carried out in the Department of Clinical Pathology, PGIMER, Dr. Ram Manohar Lohia Hospital, New Delhi. It included antenatal pregnant females brought for routine check-up as well as referred patients suspected of having hemoglobinopathies. High Performance liquid chromatography was used as a confirmatory test for identification of hemoglobinopathy. Total 20 cases of subtype homozygous HbE (3), HbE trait (12) and Eβ-thalassemia (5) were identified. Statistical analysis was done to find out correlation between levels of HBA2, HBF with RBC indices. (a) There was negative correlation between HbA2/E peak values and RBC indices (Mean corpuscular volume (MCV) and Mean corpuscular hemoglobin) among all the three groups taken together. (b) There was positive correlation between HbA2/E and Red cell distribution width (RDW). (c) There was positive correlation between HbF values with MCV. The finding of positive correlation between HbA2/E and RDW may help in differentiating βthal (RDW normal) from HbE/βthal. In a patient with microcytic hypochromic blood picture and increased RDW, diagnosis of HbE/βthal should also be considered along with the more common Iron deficiency anemia. Thus, new insights into the knowledge of these diseases are important because they impart diagnostic challenges to all the experts involved in the treatment of anemic patients.

Entities:  

Keywords:  HPLC; Hemoglobin E; Hemoglobinopathy; RBC indices; Thallasemia

Year:  2012        PMID: 24426328      PMCID: PMC3572259          DOI: 10.1007/s12288-011-0140-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  8 in total

1.  Correlation between some discrimination functions and hemoglobin E.

Authors:  W Ittarat; S Ongcharoenjai; O Rayatong; N Pirat
Journal:  J Med Assoc Thai       Date:  2000-03

2.  Spectrum of Haemoglobinopathies in a Tertiary Care Hospital of Armed Forces.

Authors:  G S Chopra; V Nair; P K Gupta; D K Mishra; A Sharma; O P Mathew
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Usefulness of certain red blood cell indices in diagnosing and differentiating thalassemia trait from iron-deficiency anemia.

Authors:  M M Eldibany; K F Totonchi; N J Joseph; D Rhone
Journal:  Am J Clin Pathol       Date:  1999-05       Impact factor: 2.493

Review 4.  Hemoglobin e syndromes.

Authors:  Elliott Vichinsky
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

5.  Hemoglobin E disorders in Eastern Uttar Pradesh.

Authors:  Shashikant C U Patne; Jyoti Shukla
Journal:  Indian J Pathol Microbiol       Date:  2009 Jan-Mar       Impact factor: 0.740

6.  Hemoglobin E disease in North Indian population: a report of 11 cases.

Authors:  Bimal Kishore; Pratima Khare; Rashmi Jain Gupta; Sonali Bisht; Kaushik Majumdar
Journal:  Hematology       Date:  2007-08       Impact factor: 2.269

7.  Red cell indices and therapeutic trial of iron in diagnostic work-up for anemic Thai females.

Authors:  Issarang Nuchprayoon; Boonruen Sukthawee; Thassanee Nuchprayoon
Journal:  J Med Assoc Thai       Date:  2003-06

Review 8.  The hemoglobin E syndromes.

Authors:  D C Rees; L Styles; E P Vichinsky; J B Clegg; D J Weatherall
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

  8 in total
  1 in total

1.  Phenotypic Diversity and Clinico-Hematological Profile of Hb E-Beta Thalassemic Children.

Authors:  Aditi Baruah; Mrinal Kumar Baruah
Journal:  Indian J Hematol Blood Transfus       Date:  2019-07-04       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.